TGF-beta Family
Available Resources for the Study of TGF-beta Family
Creative BioMart is committed to driving research in the field of TGF-beta family. Our goal is to provide researchers with the most up-to-date tools and information related to TGF-beta family modulators, TGF-beta family receptors, and TGF-beta family ligands.
- We offer a wide array of products including recombinant proteins, pre-coupled magnetic beads, cell and tissue lysates, and more, all of which are essential for understanding the functions and mechanisms of the TGF-beta family.
- Our team of experts is highly experienced in TGF-beta family research and is dedicated to creating tailored solutions to meet the specific needs of researchers.
- Additionally, we provide comprehensive resources such as invovled pathways, protein function, interacting proteins, and other valuable information to support research efforts and maximize their impact.
Our Featured Products
About TGF-beta Family
The TGF-beta (Transforming Growth Factor-beta) family is a group of signaling molecules that play crucial roles in numerous biological processes. It is a superfamily that consists of ligands, receptors, and modulators. Here's an introduction to the components of the TGF-beta family:
Ligands
The TGF-beta family includes various ligands that transmit signals to cells through receptor activation.
- TGF-beta ligands: This subgroup includes TGF-beta1, TGF-beta2, and TGF-beta3. They regulate cell growth, differentiation, apoptosis, immune response, and tissue development.
- Bone Morphogenetic Proteins (BMPs): BMPs, such as BMP2, BMP4, and BMP7, play key roles in bone and cartilage development, as well as in the regulation of cell differentiation and proliferation.
- Activins: Activins are involved in various processes, including embryonic development, cell differentiation, and reproductive functions.
- Nodal: Nodal is crucial for embryonic patterning and plays a role in left-right axis specification.
- Growth and Differentiation Factors (GDFs): GDFs, such as GDF5 and GDF11, are involved in cell growth, differentiation, and tissue development.
Receptors
TGF-beta ligands exert their effects by binding to specific cell surface receptors, which transmit the signals to the cell interior.
- Type I Receptors: The TGF-beta superfamily has several type I receptors, including TGF-beta receptor type I (TGFBR1/ALK5), Activin receptor-like kinase (ALK) receptors, and BMP type I receptors. These receptors phosphorylate and activate downstream signaling molecules.
- Type II Receptors: TGF-beta receptors type II (TGFBR2) and BMP type II receptors bind to TGF-beta and BMP ligands, respectively, forming a complex with the type I receptors to initiate signaling cascades.
Modulators
TGF-beta family modulators regulate the activity and signaling of TGF-beta ligands, fine-tuning the cellular responses to these ligands.
- Activators/Enhancers: Certain proteins, like fibrillins and latent TGF-beta binding proteins (LTBPs), interact with TGF-beta ligands and facilitate their activation or release from latent complexes.
- Inhibitors/Suppressors: Proteins such as Smad7, inhibitory Smads (I-Smads), follistatin, and gremlin, negatively regulate TGF-beta signaling by inhibiting receptor activation or ligand-receptor interactions.
- Co-receptors/Co-factors: Proteins like beta glycan (TGF-beta type III receptor), endoglin, and Cripto-1 interact with TGF-beta ligands or receptors, modulating their binding and signaling.
- Extracellular Matrix (ECM) Components: Components of the ECM, such as heparan sulfate proteoglycans (HSPGs) and integrins, interact with TGF-beta ligands, receptors, and modulators, influencing their availability and activity.
The TGF-beta family, consisting of ligands, receptors, and modulators, is involved in numerous biological processes, including development, cell proliferation and differentiation, immune response, wound healing, tissue homeostasis, and disease pathogenesis. The intricate interactions between these components regulate the intensity, duration, and specificity of TGF-beta signaling, ultimately influencing cellular behavior and tissue function. Understanding the complex network of TGF-beta family components is crucial for unraveling their roles in health and disease and for developing targeted therapies.
Fig.1 Ligand, receptor, and Smad relationships in the TGFβ system. (Massagué J, et al., 2000)
Importance of the TGF-beta Family in Disease
The TGF-beta (Transforming Growth Factor-beta) family plays a significant role in the pathogenesis of various diseases. Dysregulation of TGF-beta signaling has been implicated in several pathological conditions, highlighting the importance of this family in disease development and progression. Here are some examples of the significance of the TGF-beta family in disease:
Cancer
- TGF-beta signaling has both tumor-suppressive and tumor-promoting effects, depending on the context and stage of cancer.
- In the early stages, TGF-beta acts as a tumor suppressor by inhibiting cell proliferation, promoting apoptosis, and restraining immune responses.
- However, in advanced stages, cancer cells can develop resistance to TGF-beta-induced growth inhibition and acquire pro-tumorigenic properties.
- TGF-beta promotes tumor progression by promoting epithelial-mesenchymal transition (EMT), angiogenesis, immune evasion, and metastasis.
- Targeting TGF-beta signaling is being explored as a therapeutic strategy to inhibit tumor growth, metastasis, and enhance the efficacy of cancer treatments.
Fibrosis
- TGF-beta signaling is a major driver of tissue fibrosis, characterized by excessive accumulation of extracellular matrix components and tissue scarring.
- In conditions such as liver fibrosis, pulmonary fibrosis, and kidney fibrosis, sustained activation of the TGF-beta pathway leads to the activation of fibroblasts, differentiation into myofibroblasts, and increased production of collagen and other components of the extracellular matrix.
- This excessive fibrotic response disrupts tissue architecture and impairs organ function.
- Targeting TGF-beta signaling or its downstream effectors is being explored as a potential therapeutic approach to mitigate fibrosis.
Autoimmune Disorders
- TGF-beta signaling plays a crucial role in regulating immune responses and maintaining immune tolerance.
- Dysregulation of TGF-beta signaling can contribute to the development of autoimmune disorders, such as rheumatoid arthritis, systemic lupus erythematosus, and multiple sclerosis.
- Reduced TGF-beta signaling or impaired responsiveness to TGF-beta can lead to dysregulated immune cell activation, loss of immune tolerance, and chronic inflammation.
- Modulating TGF-beta signaling is being investigated as a potential therapeutic approach to restore immune homeostasis and suppress autoimmune responses.
Cardiovascular Disease
- TGF-beta signaling is involved in the pathogenesis of cardiovascular diseases, including cardiac fibrosis, hypertrophy, and atherosclerosis.
- Excessive TGF-beta signaling can contribute to cardiac remodeling, fibrotic tissue deposition, and impaired contractility.
- In atherosclerosis, TGF-beta signaling is implicated in the regulation of smooth muscle cell proliferation, migration, and extracellular matrix remodeling within the vessel walls.
- Targeting TGF-beta signaling is being explored as a potential therapeutic strategy to mitigate cardiac remodeling and atherosclerosis progression.
These examples highlight the importance of the TGF-beta family in various diseases. Dysregulation of TGF-beta signaling can contribute to disease pathogenesis by promoting tumor growth, fibrosis, autoimmunity, and cardiovascular dysfunction. Understanding the intricacies of TGF-beta signaling in disease contexts offers opportunities for developing targeted therapies to modulate TGF-beta pathway activity and ameliorate disease progression.
We are committed to helping you achieve your scientific goals and make meaningful contributions to research on the roles of the various components of the TGF-beta family and their role in disease. Contact us today to learn more about our products and resources.
References:
- Massagué J, Blain SW, Lo RS. TGFbeta signaling in growth control, cancer, and heritable disorders. Cell. 2000;103(2):295-309. doi:10.1016/s0092-8674(00)00121-5
- Peng D, Fu M, Wang M, Wei Y, Wei X. Targeting TGF-β signal transduction for fibrosis and cancer therapy. Mol Cancer. 2022;21(1):104. Published 2022 Apr 23. doi:10.1186/s12943-022-01569-x
